Annual report pursuant to Section 13 and 15(d)

Investment (Details)

v3.20.4
Investment (Details) - USD ($)
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Schedule of Equity Method Investments [Line Items]    
Equity in losses on equity method investment $ 262,861 $ 0
Equity in losses on equity method investment (262,861) 0
DepYmed    
Schedule of Equity Method Investments [Line Items]    
Fair value of DepYmed common shares assumed in connection with acquisition of Ohr 487,398 487,398
Equity in losses on equity method investment (262,861)  
Carrying value of DepYmed common shares 224,537 487,398
Fair value of DepYmed preferred shares assumed in connection with acquisition of Ohr 99,020 99,020
Total Investment 323,557 586,418
Equity in losses on equity method investment 262,861  
Carrying amount of the investment $ 323,557 $ 586,418